Novolog Pharm-Up 1966 Ltd Reports Earnings Results for the Full Year Ended December 31, 2020 - Marketscreener.com
| NVLG Stock | 169.40 0.30 0.18% |
About 56% of Novolog Pharm's investor base is looking to short. The analysis of current outlook of investing in Novolog Pharm Up 1966 suggests that many traders are alarmed regarding Novolog Pharm's prospects. The current market sentiment, together with Novolog Pharm's historical and current headlines, can help investors time the market. In addition, many technical investors use Novolog Pharm Up stock news signals to limit their universe of possible portfolio assets.
Novolog |
Novolog Pharm-Up 1966 Ltd Reports Earnings Results for the Full Year Ended December 31, 2020 Marketscreener.com
Read at news.google.com
 |
Novolog Pharm Fundamental Analysis
We analyze Novolog Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novolog Pharm using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novolog Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Annual Yield
Annual Yield Comparative Analysis
Novolog Pharm is currently under evaluation in annual yield category among its peers. Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Novolog Pharm Up Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Novolog Pharm stock to make a market-neutral strategy. Peer analysis of Novolog Pharm could also be used in its relative valuation, which is a method of valuing Novolog Pharm by comparing valuation metrics with similar companies.
Peers
Novolog Pharm Related Equities
| BEZQ | Bezeq Israeli | 0.81 |
| ||
| AZRG | Azrieli | 1.03 |
| ||
| NVMI | Nova | 1.41 |
| ||
| TDRN | Tadiran Hldg | 1.67 |
| ||
| ENLT | Enlight Renewable | 2.01 |
|
Complementary Tools for Novolog Stock analysis
When running Novolog Pharm's price analysis, check to measure Novolog Pharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novolog Pharm is operating at the current time. Most of Novolog Pharm's value examination focuses on studying past and present price action to predict the probability of Novolog Pharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novolog Pharm's price. Additionally, you may evaluate how the addition of Novolog Pharm to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |